UK's Halma gains on upbeat H1 forecast
** Shares of health and safety device maker Halma HLMA.L rise as much as 3% to 2,675p, their highest since mid-July
** Stock among top pct gainers on FTSE 100 .FTSE index which is up 0.2%
** Co expects to deliver "good" organic constant currency revenue growth in H1, with higher YTD order intake than the comparable period year ago
** Sees H1 adjusted operating profit margin modestly higher from 20% a year ago
** "Halma's decentralised business model and product focus have again allowed it to successfully navigate a subdued industrial backdrop" - Barclays
** Stock up 2.6% at 1145 GMT, taking YTD gains to around 17%
Reporting by Aby Jose Koilparambil in Bengaluru
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
